Nifty
Sensex
:
:
11513.90
39052.06
49.90 (0.44%)
453.07 (1.17%)

Pharmaceuticals & Drugs

Rating :
40/99

BSE: 532649 | NSE: NECLIFE

11.45
17-Oct-2019
  • Open
  • High
  • Low
  • Previous Close
  •  11.40
  •  11.80
  •  10.90
  •  11.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  160620
  •  18.27
  •  24.30
  •  10.90

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 250.95
  • 5.27
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,133.07
  • 0.45%
  • 0.22

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.80%
  • 17.38%
  • 20.79%
  • FII
  • DII
  • Others
  • 0.01%
  • 0.00%
  • 6.02%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.66
  • 11.12
  • 19.22

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.07
  • -0.23
  • 3.31

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -6.43
  • -6.51
  • -4.96

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.77
  • 12.28
  • 11.50

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.64
  • 0.71
  • 0.58

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.46
  • 6.07
  • 5.97

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Net Sales
638.92
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
576.92
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
61.99
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
9.70%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
2.13
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
31.47
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
16.40
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
16.25
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
2.55
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
13.70
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
2.14%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.61
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
-
2,782.86
2,068.66
1,643.70
1,675.69
1,643.64
1,638.31
1,626.25
1,313.11
1,062.06
845.80
Net Sales Growth
-
34.52%
25.85%
-1.91%
1.95%
0.33%
0.74%
23.85%
23.64%
25.57%
 
Cost Of Goods Sold
-
2,217.70
1,367.01
1,154.31
1,174.12
1,141.33
1,154.68
1,142.12
906.71
711.07
544.31
Gross Profit
-
565.16
701.65
489.39
501.57
502.31
483.63
484.13
406.40
350.99
301.49
GP Margin
-
20.31%
33.92%
29.77%
29.93%
30.56%
29.52%
29.77%
30.95%
33.05%
35.65%
Total Expenditure
-
2,518.70
1,832.51
1,419.29
1,436.94
1,376.73
1,350.44
1,336.10
1,064.59
834.89
650.85
Power & Fuel Cost
-
103.47
91.85
75.44
87.89
79.60
66.10
60.94
41.89
33.95
28.92
% Of Sales
-
3.72%
4.44%
4.59%
5.25%
4.84%
4.03%
3.75%
3.19%
3.20%
3.42%
Employee Cost
-
76.54
74.65
75.54
78.38
58.93
47.97
45.64
43.94
33.79
28.96
% Of Sales
-
2.75%
3.61%
4.60%
4.68%
3.59%
2.93%
2.81%
3.35%
3.18%
3.42%
Manufacturing Exp.
-
50.38
52.90
53.32
39.56
37.05
33.57
34.04
29.74
23.92
12.73
% Of Sales
-
1.81%
2.56%
3.24%
2.36%
2.25%
2.05%
2.09%
2.26%
2.25%
1.51%
General & Admin Exp.
-
21.82
23.02
20.07
20.36
21.60
22.03
18.43
17.17
13.13
17.72
% Of Sales
-
0.78%
1.11%
1.22%
1.22%
1.31%
1.34%
1.13%
1.31%
1.24%
2.10%
Selling & Distn. Exp.
-
45.66
221.12
39.00
35.24
35.25
24.71
29.84
18.48
14.84
14.41
% Of Sales
-
1.64%
10.69%
2.37%
2.10%
2.14%
1.51%
1.83%
1.41%
1.40%
1.70%
Miscellaneous Exp.
-
3.12
1.95
1.61
1.41
2.97
1.38
5.09
6.66
4.19
14.41
% Of Sales
-
0.11%
0.09%
0.10%
0.08%
0.18%
0.08%
0.31%
0.51%
0.39%
0.45%
EBITDA
-
264.16
236.15
224.41
238.75
266.91
287.87
290.15
248.52
227.17
194.95
EBITDA Margin
-
9.49%
11.42%
13.65%
14.25%
16.24%
17.57%
17.84%
18.93%
21.39%
23.05%
Other Income
-
6.04
6.04
22.67
5.78
20.00
12.53
16.04
12.89
13.46
19.40
Interest
-
148.14
115.20
117.41
123.31
125.59
137.99
115.49
115.25
74.09
60.30
Depreciation
-
63.26
64.31
62.25
57.39
76.56
84.19
75.96
60.73
46.10
38.75
PBT
-
58.82
62.68
67.42
63.83
84.75
78.23
114.75
85.43
120.44
115.30
Tax
-
11.22
10.41
12.08
9.59
18.49
16.14
29.01
12.22
16.24
23.01
Tax Rate
-
19.08%
16.61%
17.92%
15.02%
21.82%
20.63%
25.28%
14.30%
13.48%
19.96%
PAT
-
47.60
52.27
55.34
54.24
66.26
62.09
85.74
73.22
104.20
92.29
PAT before Minority Interest
-
47.60
52.27
55.34
54.24
66.26
62.09
85.74
73.22
104.20
92.29
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
1.71%
2.53%
3.37%
3.24%
4.03%
3.79%
5.27%
5.58%
9.81%
10.91%
PAT Growth
-
-8.93%
-5.55%
2.03%
-18.14%
6.72%
-27.58%
17.10%
-29.73%
12.90%
 
Unadjusted EPS
-
2.12
2.33
2.47
2.42
2.95
2.77
3.82
3.26
4.65
5.83

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
1,105.16
1,058.66
1,006.68
954.08
957.95
927.06
867.60
784.46
721.13
620.65
Share Capital
22.43
22.43
22.43
22.43
22.43
22.43
22.43
22.43
22.43
22.43
Total Reserves
1,082.73
1,036.23
984.25
931.65
935.52
904.64
845.17
762.04
698.71
598.22
Non-Current Liabilities
299.92
355.84
295.58
362.30
396.92
340.94
361.54
432.02
288.67
651.08
Secured Loans
164.40
218.21
161.20
243.44
264.36
222.59
260.48
362.93
233.60
451.02
Unsecured Loans
1.19
1.87
2.60
1.96
1.17
0.75
0.48
0.69
0.74
149.88
Long Term Provisions
9.36
9.07
8.49
6.91
6.01
4.90
3.79
3.43
2.41
0.00
Current Liabilities
1,299.90
1,309.32
1,278.66
1,239.95
1,155.60
1,126.07
1,044.90
904.38
802.79
208.76
Trade Payables
531.46
539.42
528.10
496.78
455.58
440.06
382.52
194.49
139.83
134.52
Other Current Liabilities
122.62
123.40
106.88
107.95
90.50
86.72
131.28
129.87
245.93
9.28
Short Term Borrowings
635.97
634.08
630.34
627.24
595.30
579.84
509.11
565.21
330.01
0.00
Short Term Provisions
9.87
12.41
13.34
7.98
14.22
19.45
22.00
14.81
87.02
64.96
Total Liabilities
2,704.98
2,723.82
2,580.92
2,556.33
2,510.47
2,394.07
2,274.04
2,120.86
1,812.59
1,480.49
Net Block
824.82
852.35
881.24
905.58
933.73
947.54
913.84
857.87
736.26
627.26
Gross Block
1,490.49
1,381.56
1,363.67
1,383.66
1,451.42
1,341.15
1,223.31
1,091.46
909.26
754.17
Accumulated Depreciation
665.68
529.20
482.43
478.08
517.69
393.61
309.47
233.59
173.00
126.91
Non Current Assets
1,035.96
1,063.21
1,085.05
1,091.92
1,105.54
1,156.72
1,122.94
1,071.18
868.56
682.51
Capital Work in Progress
99.55
99.79
102.11
99.35
91.31
122.26
138.57
150.13
82.42
55.51
Non Current Investment
0.27
0.27
0.27
0.27
0.15
0.05
0.05
0.05
0.05
-0.26
Long Term Loans & Adv.
108.33
104.19
96.90
82.24
80.34
86.87
70.48
63.12
49.84
0.00
Other Non Current Assets
2.99
6.61
4.53
4.47
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
1,669.03
1,660.61
1,495.86
1,464.42
1,369.02
1,237.34
1,151.08
1,049.67
944.00
797.94
Current Investments
0.51
0.51
0.41
0.52
0.44
0.31
0.32
0.14
5.33
21.32
Inventories
917.97
859.43
854.65
836.71
790.98
758.43
676.00
591.42
470.88
396.35
Sundry Debtors
558.73
611.97
499.73
491.45
446.50
376.65
349.39
304.49
311.13
222.46
Cash & Bank
21.33
9.31
13.18
36.65
33.38
9.98
6.24
25.93
32.58
34.79
Other Current Assets
170.49
54.82
53.88
31.54
97.73
91.97
119.13
127.70
124.08
123.02
Short Term Loans & Adv.
98.69
124.56
74.01
67.55
84.61
69.02
86.84
105.05
102.03
96.55
Net Current Assets
369.13
351.29
217.20
224.47
213.42
111.27
106.18
145.29
141.21
589.18
Total Assets
2,704.99
2,723.82
2,580.91
2,556.34
2,510.47
2,394.07
2,274.04
2,120.87
1,812.59
1,480.49

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
239.24
65.17
198.76
168.82
144.41
254.87
360.83
164.96
43.81
55.31
PBT
58.82
62.68
67.42
64.74
84.75
78.22
114.75
85.43
120.44
115.30
Adjustment
207.17
175.82
158.85
174.16
185.24
212.94
179.63
156.84
122.10
84.05
Changes in Working Capital
-13.19
-160.72
-20.34
-61.52
-119.29
-16.31
68.28
-64.33
-186.05
-131.53
Cash after chg. in Working capital
252.79
77.79
205.93
177.38
150.70
274.85
362.66
177.94
56.48
67.81
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-13.56
-12.62
-7.17
-8.56
-6.29
-19.98
-1.83
-12.98
-12.67
-12.50
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-26.13
-29.43
-18.10
-76.88
-59.53
-89.99
-98.95
-233.56
-168.65
-145.57
Net Fixed Assets
-108.69
-15.57
17.23
59.72
-79.32
-101.53
-120.29
-249.91
-182.00
-121.21
Net Investments
0.00
-0.10
0.11
-0.53
-0.23
0.01
-0.18
5.19
20.32
-20.09
Others
82.56
-13.76
-35.44
-136.07
20.02
11.53
21.52
11.16
-6.97
-4.27
Cash from Financing Activity
-201.09
-39.60
-204.12
-88.68
-61.47
-161.14
-281.56
61.95
122.63
90.57
Net Cash Inflow / Outflow
12.02
-3.87
-23.47
3.27
23.40
3.74
-19.68
-6.65
-2.21
0.32
Opening Cash & Equivalents
9.31
13.18
36.65
33.38
9.98
6.24
25.93
32.58
34.79
34.47
Closing Cash & Equivalent
21.33
9.31
13.18
36.65
33.38
9.98
6.24
25.93
32.58
34.79

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
49.28
47.21
44.89
42.54
41.11
41.34
38.69
34.98
32.15
27.67
ROA
1.75%
1.97%
2.15%
2.14%
2.70%
2.66%
3.90%
3.72%
6.33%
6.67%
ROE
4.40%
5.06%
5.64%
5.78%
7.17%
6.92%
10.38%
9.73%
15.53%
19.98%
ROCE
10.29%
9.13%
9.73%
9.95%
11.58%
12.24%
12.88%
12.00%
14.21%
15.76%
Fixed Asset Turnover
2.11
1.52
1.27
1.26
1.25
1.33
1.45
1.35
1.35
1.29
Receivable days
68.64
96.93
103.72
95.49
85.98
77.54
71.26
83.13
86.76
80.29
Inventory Days
104.21
149.46
176.99
165.71
161.85
153.20
138.12
143.44
141.01
153.69
Payable days
72.05
102.40
128.03
119.13
113.39
105.76
76.22
54.56
55.61
85.15
Cash Conversion Cycle
100.79
143.99
152.69
142.07
134.44
124.98
133.15
172.00
172.16
148.82
Total Debt/Equity
0.82
0.90
0.87
1.01
1.00
0.93
1.01
1.33
1.10
0.97
Interest Cover
1.40
1.54
1.57
1.52
1.67
1.57
1.99
1.74
2.63
2.91

News Update:


  • Fire breaks out at Punjab Unit of Nectar Lifesciences
    26th Aug 2019, 11:12 AM

    The company is taking the necessary steps to restore the normalcy of production

    Read More
  • Nectar Lifesciences - Quarterly Results
    14th Aug 2019, 14:29 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.